MANKIND PHARMA
Back to Income Statement
|
MANKIND PHARMA Last 5 Year Operating Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹3,622 Cr | ₹3,020 Cr | ₹2,515 Cr | ₹1,902 Cr | ₹1,991 Cr |
What is the latest Operating Profit of MANKIND PHARMA ?
| Year | Operating Profit |
|---|---|
| Mar2026 | ₹3,622 Cr |
| Mar2025 | ₹3,020 Cr |
| Mar2024 | ₹2,515 Cr |
| Mar2023 | ₹1,902 Cr |
| Mar2022 | ₹1,991 Cr |
How is Operating Profit of MANKIND PHARMA Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹3,622 Cr | 19.93 | |
| Mar2025 | ₹3,020 Cr | 20.09 | |
| Mar2024 | ₹2,515 Cr | 32.24 | |
| Mar2023 | ₹1,902 Cr | -4.45 | |
| Mar2022 | ₹1,991 Cr | - | |
Compare Operating Profit of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹104,509.7 Cr | 1.7% | 6.4% | 4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,507.0 Cr | 2.8% | 7.4% | 14.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹190,744.0 Cr | 6.4% | 8.3% | 0.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹168,250.0 Cr | 2.1% | 8.7% | 47.7% | Stock Analytics | |
| CIPLA | ₹116,213.0 Cr | 0.5% | 3.6% | -5.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,980.0 Cr | -7.6% | -2.2% | -5.8% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | 1.7% |
6.4% |
4% |
| SENSEX | -1.4% |
4.4% |
-7.6% |
You may also like the below Video Courses